REPL
Replimune Group, Inc.
- Latest sale
- $350k
- Nov 16 · No plan
- Form 4 sales
- 127
- On record
- Form 144 notices
- 6
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planAug 10 2026
Sold 39,341 shares at $12.97 ($510k)
Patel Sushil, Chief Executive Officer
No 10b5-1 planSold 5.3% of holdings ($9.7M position)708,151 shares left2.2x usual sizeFiling
- 2 Form 4 saleNo planAug 17 +7 days
Sold 9,256 shares at $14.28 ($132k)
Hill Emily Luisa, Chief Financial Officer
No 10b5-1 planSold 4.1% of holdings ($3.2M position)215,852 shares left1.1x usual sizeFiling
- 3 Form 4 saleNo planNov 16 +91 days
Sold 14,709 shares at $21.60 ($318k)
Hill Emily Luisa, Chief Financial Officer
No 10b5-1 planSold 6.8% of holdings ($4.7M position)201,143 shares left1.6x usual sizeFiling
- 4 Form 4 saleNo planNov 16 same day
Sold 49,026 shares at $21.60 ($1.1M)
Patel Sushil, Chief Executive Officer
No 10b5-1 planSold 6.9% of holdings ($15.3M position)659,125 shares left2x usual sizeFiling
- 5 Form 4 saleNo planNov 16 same day
Sold 2,148 shares at $21.60 ($46k)
Schwendenman Andrew, Chief Accounting Officer
No 10b5-1 planSold 2.2% of holdings ($2.1M position)97,277 shares left0.3x usual sizeFiling
- 6 Form 4 saleNo planNov 16 same day
Sold 16,198 shares at $21.60 ($350k)
Xynos Konstantinos, Chief Medical Officer
No 10b5-1 planSold 7.2% of holdings ($4.8M position)208,017 shares left2x usual sizeFiling
- 7 Form 144 noticeNoticeNov 19 +3 days
Filed to sell 83,758 shares ($1.7M)
Xynos Konstantinos, Officer
10b5-1 plan8.6x usual sizeFiling
- 8 Form 144 noticeNoticeNov 20 +1 day
Filed to sell 15,331 shares ($288k)
Patel Sushil, Chief Strategy Officer
10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (133)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2026 | Patel Sushil | Chief Strategy Officer | Form 144 notice | 15,331 | $288k | Notice | SEC | |
| Nov 19, 2026 | Xynos Konstantinos | Officer | Form 144 notice | 83,758 | $1.7M | Notice | SEC | |
| Nov 16, 2026 | Xynos Konstantinos | Chief Medical Officer | Form 4 sale | 16,198 | $350k | 7.2% | No plan | SEC |
| Nov 16, 2026 | Schwendenman Andrew | Chief Accounting Officer | Form 4 sale | 2,148 | $46k | 2.2% | No plan | SEC |
| Nov 16, 2026 | Patel Sushil | Chief Executive Officer | Form 4 sale | 49,026 | $1.1M | 6.9% | No plan | SEC |
| Nov 16, 2026 | Hill Emily Luisa | Chief Financial Officer | Form 4 sale | 14,709 | $318k | 6.8% | No plan | SEC |
| Aug 17, 2026 | Hill Emily Luisa | Chief Financial Officer | Form 4 sale | 9,256 | $132k | 4.1% | No plan | SEC |
| Aug 10, 2026 | Patel Sushil | Chief Executive Officer | Form 4 sale | 39,341 | $510k | 5.3% | No plan | SEC |
| Aug 10, 2026 | Hill Emily Luisa | Chief Financial Officer | Form 4 sale | 11,448 | $148k | 4.8% | No plan | SEC |
| Aug 10, 2026 | Xynos Konstantinos | Chief Medical Officer | Form 4 sale | 11,447 | $148k | 4.9% | No plan | SEC |
| Aug 10, 2026 | Schwendenman Andrew | Chief Accounting Officer | Form 4 sale | 7,632 | $99k | 7.1% | No plan | SEC |
| Jun 1, 2026 | Sarchi Christopher | Chief Commercial Officer | Form 4 sale | 12,000 | $111k | 6.2% | Routine | SEC |
| May 18, 2026 | Xynos Konstantinos | Chief Medical Officer | Form 4 sale | 14,023 | $71k | 5.6% | No plan | SEC |
| May 18, 2026 | Schwendenman Andrew | Chief Accounting Officer | Form 4 sale | 7,894 | $40k | 6.9% | No plan | SEC |
| May 18, 2026 | Sarchi Christopher | Chief Commercial Officer | Form 4 sale | 8,626 | $44k | 4.3% | No plan | SEC |
| May 18, 2026 | Astley-Sparke Philip | Director | Form 4 sale | 17,657 | $90k | 1.2% | No plan | SEC |
| May 18, 2026 | Patel Sushil | Chief Executive Officer | Form 4 sale | 37,324 | $190k | 4.8% | Unusual | SEC |
| May 18, 2026 | Hill Emily Luisa | Chief Financial Officer | Form 4 sale | 7,812 | $40k | 3.2% | No plan | SEC |
| Apr 2, 2026 | Sarchi Christopher | Chief Commercial Officer | Form 4 sale | 6,500 | $52k | 4.1% | Routine | SEC |
| Dec 9, 2025 | Dhingra Kapil | Director | Form 4 sale | 3,169 | $33k | 100.0% | Unusual | SEC |
| Dec 2, 2025 | Patel Sushil | Chief Executive Officer | Form 4 sale | 10,000 | $111k | 2.9% | Routine | SEC |
| Nov 17, 2025 | Sarchi Christopher | Chief Commercial Officer | Form 4 sale | 5,208 | $47k | 4.1% | No plan | SEC |
| Nov 17, 2025 | Xynos Konstantinos | Chief Medical Officer | Form 4 sale | 7,248 | $66k | 4.9% | No plan | SEC |
| Aug 15, 2025 | Hill Emily Luisa | Chief Financial Officer | Form 4 sale | 9,154 | $49k | 6.4% | No plan | SEC |
| May 20, 2025 | Astley-Sparke Philip | Director | Form 4 sale | 32,279 | $260k | 2.2% | No plan | SEC |
| May 20, 2025 | Xynos Konstantinos | Chief Medical Officer | Form 4 sale | 7,952 | $64k | 5.1% | No plan | SEC |
| May 20, 2025 | Schwendenman Andrew | Chief Accounting Officer | Form 4 sale | 3,287 | $26k | 4.6% | No plan | SEC |
| May 20, 2025 | Patel Sushil | Chief Executive Officer | Form 4 sale | 25,105 | $202k | 6.8% | No plan | SEC |
| May 20, 2025 | Hill Emily Luisa | Chief Financial Officer | Form 4 sale | 2,535 | $20k | 1.7% | No plan | SEC |
| May 20, 2025 | Sarchi Christopher | Chief Commercial Officer | Form 4 sale | 3,749 | $30k | 2.8% | No plan | SEC |
| Dec 16, 2024 | Patel Sushil | Chief Executive Officer | Form 4 sale | 10,000 | $124k | 4.7% | Routine | SEC |
| Dec 16, 2024 | Patel Sushil | Chief Strategy Officer | Form 144 notice | 15,000 | $189k | Notice | SEC | |
| Nov 18, 2024 | Xynos Konstantinos | Chief Medical Officer | Form 4 sale | 7,246 | $78k | 6.2% | No plan | SEC |
| Nov 18, 2024 | Sarchi Christopher | Chief Commercial Officer | Form 4 sale | 5,207 | $56k | 5.6% | No plan | SEC |
| Aug 16, 2024 | Hill Emily Luisa | Chief Financial Officer | Form 4 sale | 8,938 | $91k | 8.1% | No plan | SEC |
| Jun 7, 2024 | Xynos Konstantinos | Chief Medical Officer | Form 4 sale | 15,881 | $119k | 11.9% | Routine | SEC |
| May 16, 2024 | Sarchi Christopher | Chief Commercial Officer | Form 4 sale | 2,218 | $14k | 2.3% | No plan | SEC |
| May 16, 2024 | Schwendenman Andrew | Chief Accounting Officer | Form 4 sale | 2,298 | $15k | 5.7% | No plan | SEC |
| May 16, 2024 | Love Colin | Chief Operating Officer | Form 4 sale | 17,615 | $114k | 2.2% | No plan | SEC |
| May 16, 2024 | Astley-Sparke Philip | Executive Chairman | Form 4 sale | 37,928 | $245k | 2.5% | No plan | SEC |
| May 16, 2024 | Coffin Robert | Director | Form 4 sale | 11,464 | $74k | 0.6% | No plan | SEC |
| May 16, 2024 | Patel Sushil | Chief Executive Officer | Form 4 sale | 20,194 | $131k | 8.7% | No plan | SEC |
| May 16, 2024 | Xynos Konstantinos | Chief Medical Officer | Form 4 sale | 6,367 | $41k | 4.6% | No plan | SEC |
| Nov 16, 2023 | Xynos Konstantinos | Chief Medical Officer | Form 4 sale | 7,313 | $80k | 6.1% | No plan | SEC |
| Nov 16, 2023 | Sarchi Christopher | Chief Commercial Officer | Form 4 sale | 5,255 | $57k | 6.8% | No plan | SEC |
| Sep 12, 2023 | Esposito Pamela | Chief Business Officer | Form 4 sale | 5,658 | $113k | 2.1% | Routine | SEC |
| Aug 22, 2023 | Esposito Pamela | Chief Business Officer | Form 4 sale | 18,600 | $372k | 6.6% | Unusual | SEC |
| Aug 11, 2023 | Esposito Pamela | Chief Business Officer | Form 4 sale | 1,400 | $28k | 0.5% | Routine | SEC |
| Jul 10, 2023 | Esposito Pamela | Chief Business Officer | Form 4 sale | 20,000 | $432k | 7.1% | Routine | SEC |
| Jul 10, 2023 | Esposito Pamela | Officer | Form 144 notice | 80,000 | $1.7M | Notice | SEC | |
| Jun 13, 2023 | Lewis Tanya | Chief Dev. Op. Officer | Form 4 sale | 12,860 | $309k | 8.7% | Routine | SEC |
| Jun 13, 2023 | Patel Sushil | Chief Strategy Officer | Form 4 sale | 5,698 | $137k | 3.7% | Routine | SEC |
| Jun 13, 2023 | Lewis Tanya | Affiliate | Form 144 notice | 22,486 | $527k | Notice | SEC | |
| Jun 13, 2023 | Patel Sushil | Affiliate | Form 144 notice | 23,710 | $556k | Notice | SEC | |
| May 16, 2023 | Patel Sushil | Chief Strategy Officer | Form 4 sale | 15,575 | $281k | 9.2% | No plan | SEC |
| May 16, 2023 | Coffin Robert | President & Chief R&D Officer | Form 4 sale | 7,861 | $142k | 0.4% | No plan | SEC |
| May 16, 2023 | Lewis Tanya | Chief Dev. Op. Officer | Form 4 sale | 12,207 | $220k | 7.6% | No plan | SEC |
| May 16, 2023 | Love Colin | Chief Operating Officer | Form 4 sale | 10,775 | $194k | 1.3% | No plan | SEC |
| May 16, 2023 | Franchi Jean M. | Chief Financial Officer | Form 4 sale | 11,351 | $205k | 8.1% | No plan | SEC |
| May 16, 2023 | Xynos Konstantinos | Chief Medical Officer | Form 4 sale | 771 | $14k | 0.6% | No plan | SEC |
| May 16, 2023 | Esposito Pamela | Chief Business Officer | Form 4 sale | 5,966 | $108k | 2.2% | No plan | SEC |
| May 16, 2023 | Astley-Sparke Philip | Chief Executive Officer | Form 4 sale | 17,902 | $323k | 1.2% | No plan | SEC |
| Dec 9, 2022 | Esposito Pamela | Chief Business Officer | Form 4 sale | 15,000 | $375k | 6.1% | Plan not stated | SEC |
| May 16, 2022 | Love Colin | Chief Operating Officer | Form 4 sale | 6,324 | $92k | 0.8% | Plan not stated | SEC |
| May 16, 2022 | Esposito Pamela | Chief Business Officer | Form 4 sale | 3,507 | $51k | 1.5% | Plan not stated | SEC |
| May 16, 2022 | Franchi Jean M. | Chief Financial Officer | Form 4 sale | 3,436 | $50k | 3.5% | Plan not stated | SEC |
| May 16, 2022 | Lewis Tanya | Chief Dev. Op Officer | Form 4 sale | 5,473 | $80k | 4.3% | Plan not stated | SEC |
| May 16, 2022 | Patel Sushil | Chief Commercial Officer | Form 4 sale | 10,687 | $156k | 7.6% | Plan not stated | SEC |
| May 16, 2022 | Coffin Robert | President & Chief R&D Officer | Form 4 sale | 5,737 | $84k | 0.3% | Plan not stated | SEC |
| May 16, 2022 | Astley-Sparke Philip | Chief Executive Officer | Form 4 sale | 9,632 | $141k | 0.7% | Plan not stated | SEC |
| Mar 16, 2022 | Omega Fund IV G.P. Manager, Ltd. | 10% owner | Form 4 sale | 106,500 | $1.7M | 2.2% | Unusual | SEC |
| Nov 22, 2021 | Omega Fund IV GP, L.P. | 10% owner | Form 4 sale | 45,424 | $1.6M | 0.9% | Plan not stated | SEC |
| Nov 18, 2021 | Omega Fund IV G.P. Manager, Ltd. | 10% owner | Form 4 sale | 2,594 | $87k | 0.1% | Plan not stated | SEC |
| Nov 18, 2021 | Omega Fund IV GP, L.P. | 10% owner | Form 4 sale | 2,594 | $87k | 0.1% | Plan not stated | SEC |
| Nov 15, 2021 | Omega Fund IV GP, L.P. | 10% owner | Form 4 sale | 24,017 | $808k | 0.5% | Plan not stated | SEC |
| Nov 11, 2021 | Omega Fund IV GP, L.P. | 10% owner | Form 4 sale | 18,290 | $615k | 0.4% | Plan not stated | SEC |
| Nov 9, 2021 | Omega Fund IV GP, L.P. | 10% owner | Form 4 sale | 11,354 | $382k | 0.2% | Plan not stated | SEC |
| Nov 5, 2021 | Omega Fund IV G.P. Manager, Ltd. | 10% owner | Form 4 sale | 31,015 | $1M | 0.6% | Plan not stated | SEC |
| Oct 18, 2021 | Love Colin | Chief Operating Officer | Form 4 sale | 30,000 | $902k | 3.9% | Plan not stated | SEC |
| Sep 23, 2021 | Stampacchia Otello | Director, 10% owner | Form 4 sale | 12,171 | $409k | 0.2% | Plan not stated | SEC |
| Sep 17, 2021 | Omega Fund IV, L.P. | Director, 10% owner | Form 4 sale | 100,000 | $3.3M | 2.0% | Plan not stated | SEC |
| Sep 15, 2021 | Love Colin | Chief Operating Officer | Form 4 sale | 30,000 | $937k | 3.7% | Plan not stated | SEC |
| Aug 16, 2021 | Love Colin | Chief Operating Officer | Form 4 sale | 30,000 | $898k | 3.6% | Plan not stated | SEC |
| Aug 5, 2021 | Esposito Pamela | Chief Business Officer | Form 4 sale | 30,000 | $1.1M | 12.5% | Plan not stated | SEC |
| Jul 21, 2021 | Esposito Pamela | Chief Business Officer | Form 4 sale | 17,400 | $577k | 7.6% | Plan not stated | SEC |
| Jul 15, 2021 | Esposito Pamela | Chief Business Officer | Form 4 sale | 4,600 | $154k | 2.1% | Plan not stated | SEC |
| Jul 15, 2021 | Love Colin | Chief Operating Officer | Form 4 sale | 30,000 | $961k | 3.5% | Plan not stated | SEC |
| Jul 2, 2021 | Coffin Robert | President & Chief R&D Officer | Form 4 sale | 7,810 | $313k | 0.4% | Plan not stated | SEC |
| Jun 29, 2021 | Coffin Robert | President & Chief R&D Officer | Form 4 sale | 37,489 | $1.5M | 2.1% | Plan not stated | SEC |
| Jun 15, 2021 | Love Colin | Chief Operating Officer | Form 4 sale | 30,000 | $1M | 3.3% | Plan not stated | SEC |
| Apr 15, 2021 | Love Colin | Chief Operating Officer | Form 4 sale | 30,000 | $919k | 3.2% | Plan not stated | SEC |
| Mar 15, 2021 | Love Colin | Chief Operating Officer | Form 4 sale | 30,000 | $1M | 3.3% | Plan not stated | SEC |
| Feb 16, 2021 | Love Colin | Chief Operating Officer | Form 4 sale | 30,000 | $1.1M | 3.2% | Plan not stated | SEC |
| Feb 8, 2021 | Omega Fund IV G.P. Manager, Ltd. | 10% owner | Form 4 sale | 5,249 | $236k | 0.1% | Plan not stated | SEC |
| Jan 26, 2021 | Rhodes Jason P | Director | Form 4 sale | 5,558 | $256k | 0.6% | Plan not stated | SEC |
| Jan 26, 2021 | Omega Fund IV G.P. Manager, Ltd. | 10% owner | Form 4 sale | 30,350 | $1.4M | 0.6% | Plan not stated | SEC |
| Jan 22, 2021 | Coffin Robert | President & Chief R&D Officer | Form 4 sale | 60,000 | $2.7M | 3.3% | Plan not stated | SEC |
| Jan 22, 2021 | Stampacchia Otello | Director, 10% owner | Form 4 sale | 11,359 | $512k | 0.2% | Plan not stated | SEC |
| Jan 19, 2021 | Astley-Sparke Philip | Chief Executive Officer | Form 4 sale | 50,000 | $2.2M | 3.8% | Plan not stated | SEC |
| Jan 19, 2021 | Esposito Pamela | Chief Business Officer | Form 4 sale | 55,000 | $2.4M | 23.8% | Plan not stated | SEC |
| Jan 19, 2021 | Love Colin | Chief Operating Officer | Form 4 sale | 30,000 | $1.3M | 3.1% | Plan not stated | SEC |
| Jan 15, 2021 | Omega Fund IV GP, L.P. | 10% owner | Form 4 sale | 19,580 | $883k | 0.4% | Plan not stated | SEC |
| Jan 14, 2021 | Franchi Jean M. | Chief Financial Officer | Form 4 sale | 15,000 | $668k | 100.0% | Unusual | SEC |
| Dec 22, 2020 | Coffin Robert | President & Chief R&D Officer | Form 4 sale | 220,000 | $8.8M | 10.9% | Unusual | SEC |
| Dec 18, 2020 | Rhodes Jason P | Director | Form 4 sale | 4,319 | $181k | 18.3% | Plan not stated | SEC |
| Dec 17, 2020 | Rhodes Jason P | Director | Form 4 sale | 65,029 | $2.7M | 76.9% | Unusual | SEC |
| Dec 14, 2020 | Franchi Jean M. | Chief Financial Officer | Form 4 sale | 25,000 | $1.1M | 100.0% | Unusual | SEC |
| Dec 14, 2020 | Rhodes Jason P | Director | Form 4 sale | 103,686 | $4.5M | 81.5% | Unusual | SEC |
| Dec 10, 2020 | Astley-Sparke Philip | Chief Executive Officer | Form 4 sale | 50,000 | $2.2M | 3.7% | Plan not stated | SEC |
| Dec 9, 2020 | Love Colin | Chief Operating Officer | Form 4 sale | 30,000 | $1.3M | 3.0% | Plan not stated | SEC |
| Dec 9, 2020 | Rhodes Jason P | Director | Form 4 sale | 217,362 | $10M | 88.0% | Unusual | SEC |
| Dec 8, 2020 | Slattery Joseph P | Director | Form 4 sale | 5,200 | $239k | 43.8% | Unusual | SEC |
| Dec 7, 2020 | Dhingra Kapil | Director | Form 4 sale | 40,000 | $1.8M | 100.0% | Unusual | SEC |
| Nov 16, 2020 | Love Colin | Chief Operating Officer | Form 4 sale | 15,000 | $674k | 1.5% | Plan not stated | SEC |
| Oct 14, 2020 | Esposito Pamela | Chief Business Officer | Form 4 sale | 16,000 | $526k | 12.4% | Plan not stated | SEC |
| Sep 15, 2020 | Love Colin | Chief Operating Officer | Form 4 sale | 15,000 | $359k | 1.4% | Plan not stated | SEC |
| Aug 31, 2020 | Esposito Pamela | Chief Business Officer | Form 4 sale | 5,000 | $135k | 4.2% | Plan not stated | SEC |
| Aug 17, 2020 | Love Colin | Chief Operating Officer | Form 4 sale | 15,000 | $352k | 1.4% | Plan not stated | SEC |
| Jul 9, 2020 | Coffin Robert | President & Chief R&D Officer | Form 4 sale | 169,750 | $3.8M | 7.7% | Unusual | SEC |
| Feb 20, 2020 | Coffin Robert | Pres & Chief Res & Dev Officer | Form 4 sale | 24,250 | $413k | 1.1% | Plan not stated | SEC |
| Feb 12, 2020 | Coffin Robert | Pres & Chief Res & Dev Officer | Form 4 sale | 48,500 | $826k | 2.1% | Plan not stated | SEC |
| Nov 6, 2019 | Love Colin | Chief Operating Officer | Form 4 sale | 22,500 | $383k | 2.1% | Plan not stated | SEC |
| Nov 6, 2019 | Astley-Sparke Philip | Executive Chairman | Form 4 sale | 29,000 | $493k | 2.1% | Plan not stated | SEC |
| Nov 6, 2019 | Coffin Robert | President and CEO | Form 4 sale | 48,500 | $825k | 2.1% | Plan not stated | SEC |
| Nov 4, 2019 | Astley-Sparke Philip | Executive Chairman | Form 4 sale | 29,000 | $494k | 2.1% | Plan not stated | SEC |
| Nov 4, 2019 | Love Colin | Chief Operating Officer | Form 4 sale | 22,500 | $383k | 2.1% | Plan not stated | SEC |
| Nov 4, 2019 | Coffin Robert | President and CEO | Form 4 sale | 48,500 | $826k | 2.1% | Plan not stated | SEC |
| Oct 31, 2019 | Coffin Robert | President and CEO | Form 4 sale | 24,250 | $412k | 1.0% | Plan not stated | SEC |
| Oct 31, 2019 | Astley-Sparke Philip | Executive Chairman | Form 4 sale | 14,500 | $247k | 1.0% | Plan not stated | SEC |
| Oct 31, 2019 | Love Colin | Chief Operating Officer | Form 4 sale | 11,250 | $191k | 1.0% | Plan not stated | SEC |
| Sep 23, 2019 | Astley-Sparke Philip | Executive Chairman | Form 4 sale | 14,500 | $247k | 1.0% | Plan not stated | SEC |
| Sep 23, 2019 | Love Colin | Chief Operating Officer | Form 4 sale | 11,250 | $192k | 1.0% | Plan not stated | SEC |
| Sep 23, 2019 | Coffin Robert | President and CEO | Form 4 sale | 24,250 | $413k | 1.0% | Plan not stated | SEC |